Heilongjiang ZBD Pharmaceutical Co Ltd (603567) — Capital Reinvestment Ratio
Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a Capital Reinvestment Ratio of 0.08x as of September 2025, meaning it reinvests 0% of its operating cash flow (CN¥283.54 Million) in capital expenditures (CN¥21.27 Million). See 603567 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Heilongjiang ZBD Pharmaceutical Co Ltd Capital Reinvestment Ratio (2011–2024)
This chart tracks Heilongjiang ZBD Pharmaceutical Co Ltd's Capital Reinvestment Ratio across 10 annual periods. Check Heilongjiang ZBD Pharmaceutical Co Ltd cash flow reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2024)
Year-by-year Capital Reinvestment Ratio for Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2024. For live market cap and broader valuation context, see how much is Heilongjiang ZBD Pharmaceutical Co Ltd worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 1.15x | CN¥164.31 Million | CN¥189.15 Million | ▼ -79.4% |
| 2020 | 5.60x | CN¥155.18 Million | CN¥868.65 Million | ▲ +591.7% |
| 2019 | 0.81x | CN¥220.92 Million | CN¥178.79 Million | ▼ -29.1% |
| 2018 | 1.14x | CN¥367.40 Million | CN¥419.59 Million | ▲ +97.9% |
| 2017 | 0.58x | CN¥853.19 Million | CN¥492.42 Million | ▼ -97.1% |
| 2016 | 20.14x | CN¥15.83 Million | CN¥318.74 Million | ▲ +9644.1% |
| 2014 | 0.21x | CN¥386.32 Million | CN¥79.85 Million | ▼ -78.6% |
| 2013 | 0.97x | CN¥174.68 Million | CN¥168.73 Million | ▼ -36.1% |
| 2012 | 1.51x | CN¥154.25 Million | CN¥233.09 Million | ▲ +13.2% |
| 2011 | 1.33x | CN¥104.71 Million | CN¥139.77 Million | — |